NEWSLETTER-2017

466 NEWSLETTER 2017 • The Board decided that the establishment of a joint venture by acquisition of certain amount of shares of GS Renewable Holdings GK that owns all shares of Japan Renewable Energy Corporation, by Colindale Investment Private Limited is not subject to authorization. (22.08.2017, 17-27/447-BD) • The Board authorized the indirect acquisition of Nature’s Bounty Co. by KKR & Co. L.P. (22.08.2017, 17-27/455- 196) • The Board authorized the acquisition of the shares of Biotest AG through the voluntary share purchase offer by Tiancheng Germany Pharmaceutical Holdings AG. (22.08.2017, 17- 27/437-190) • The Board authorized the acquisition of a certain number of shares of Yem-Vit Vitaminli Yem Katkı Maddeleri San. ve Tic. A.Ş. by Devenish Nutriton Limited. (22.08.2017, 17- 27/436-189) • The Board decided that the acquisition of ES Yayıncılık ve MedyaYatırımHizmetleriA.Ş. and its subsidiaries, which are incorporated within the Sancak Group by Zeki YEŞİLDAĞ, is not subject to authorization. (07.09.2017, 17-28/475-BD) • The Board decided that the indirect acquisition of the sole control of Cortefiel S.A. by CVC Capital Partners SICAV- FIS S.A via CVC Funds and by PAI Partners S.A.S via PAI IV Funds is not subject to authorization. (07.09.2017, 17- 28/474-BD) • The Board decided that the acquisition of a certain number of shares of Zetaş Zemin Teknolojisi A.Ş. by Soletanche Freyssinet SA, which currently held a certain number of sha- res of the Company, is not within the scope of an application. (07.09.2017, 17-28/473-BD) • The Board authorized the acquisition of the sole control over Eczacıbaşı-Monrol Nükleer Ürünler Tic. ve San. A.Ş. under the joint control of the Eczacıbaşı Group and Bozluolçay Fa- mily by Eczacıbaşı Holding A.Ş., EİS Eczacıbaşı İlaç Sınai